Another pharmaceutical company has recalled blood pressure medication over illness risk

  • 📰 YahooNews
  • ⏱ Reading Time:
  • 29 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 59%

South Africa News News

South Africa South Africa Latest News,South Africa South Africa Headlines

Another pharmaceutical company is recalling a blood pressure medication that could increase the risk of cancer if taken in large amounts.

On Wednesday, Lupin Pharmaceuticals recalled four lots of Quinapril Tablets because the medication has too much of the nitrosamine impurity N-Nitroso-Quinapril, the FDA announced.Quinapril Tablets USP, 20mg | lot No. G102929 | expiration date of April 2023Quinapril Tablets USP, 40mg | lot Nos. G100533, G100534, G203071 | expiration dates of December 2022 and March 2024

FDA announced Lupin Pharmaceuticals recalled four lots of Quinapril Tablets, a high blood pressure medication, due to a high amount of nitrosamine impurity. In October, Aurobindo Pharma recalled two lots of Quinapril because of the same nitrosamine impurity.What is nitrosamine and N-Nitroso-Quinapril?

However, impurities, like N-Nitroso-Quinapril, may increase the risk of cancer if people are exposed to it above acceptable levels over a long period of time.There have been no reports of illness from this recall, so consumers are not in immediate danger.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 380. in ZA

South Africa South Africa Latest News, South Africa South Africa Headlines